Streetbeat News

Stock Prices

LNW

Light & Wonder (NASDAQ:LNW) has received mixed analyst ratings over the past three months, with a majority being bullish. The average 12-month price target has increased by 8.57% to $114.0. Analysts have adjusted their ratings and price targets, reflecting positive sentiment towards the company's financial health and growth prospects.

Portfolio Pulse from Benzinga Insights

August 26, 2024 | 1:00 pm

O

Analysts have provided diverse evaluations for Realty Income (NYSE:O) over the past three months, with a mix of bullish and neutral ratings. The average 12-month price target has increased to $63.31. Realty Income has shown strong revenue growth but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

August 26, 2024 | 1:00 pm

AVB

AvalonBay Communities (NYSE:AVB) has been analyzed by 12 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has increased to $219.42. Analysts have adjusted their ratings and price targets, reflecting positive financial metrics such as revenue growth and strong profitability.

Portfolio Pulse from Benzinga Insights

August 26, 2024 | 1:00 pm

XPEV

XPeng Inc (NYSE:XPEV) saw its stock rise over 5% in premarket trading after CEO Xiaopeng acquired over 2 million shares, signaling confidence in the company's growth. Despite a 60.2% year-on-year revenue increase, XPeng missed analyst estimates. The stock has dropped 62% over the past year due to weak demand and tariffs.

Portfolio Pulse from Anusuya Lahiri

August 26, 2024 | 1:00 pm

BCAN

The trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. This update is crucial for investors tracking the affected stocks.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 12:55 pm

LAD

MA

MCD

PM

The article discusses recent insider sales of shares by executives at Lithia Motors, Philip Morris International, McDonald's, and Mastercard. Insider sales can indicate various factors, including preplanned sales or concerns about company prospects. Notably, Lithia Motors reported strong earnings, Philip Morris received an analyst price target increase, McDonald's had a price target raise, and Mastercard plans a workforce reduction.

Portfolio Pulse from Avi Kapoor

August 26, 2024 | 12:46 pm

BIIB

LLY

Eli Lilly's Alzheimer's drug, donanemab, is likely to face rejection by the UK's NHS due to safety concerns and high costs, following a similar rejection of Biogen's lecanemab. Despite donanemab's effectiveness, its side effects and projected higher costs pose significant hurdles.

Portfolio Pulse from Vandana Singh

August 26, 2024 | 12:45 pm

RYTM

Rhythm Pharmaceuticals' shares rose following the FDA's acceptance of a priority review for their supplemental NDA for IMCIVREE.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 12:45 pm

MIRA

MIRA Pharmaceuticals shares rise following positive pre-clinical study results showing Ketamir-2 significantly reverses neuropathic pain in rats.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 12:43 pm

COWZ

NNN

SHW

V

Sherwin-Williams, Visa, NNN REIT, and Pacer US Cash Cows 100 ETF were highlighted on CNBC's 'Final Trades'. Sherwin-Williams hit an all-time high and raised its 2024 EPS guidance. Visa's earnings met expectations but missed sales estimates. NNN REIT has a 5% yield and a raised price target. Pacer US Cash Cows 100 ETF is noted for high free cash flow yield.

Portfolio Pulse from Avi Kapoor

August 26, 2024 | 12:43 pm